CYP2C19 and cerebral artery stenosis: The purpose of this study was to evaluate the effect of different CYP2C19 genotypes on the clinical efficacy of clopidogrel therapy in patients receiving the drug after stent placement for cerebral arterial stenosis, in order to provide an evidence for individualized clopidogrel medication related to cerebrovascular diseases.